Dr. Leslie J. Cloud, MD
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Medical school
- Medical College of Georgia School of Medicine (2004)
- Years since graduation
- 22
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 309
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2004Medical school: Medical College of Georgia School of Medicine
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
VA license 0101248863
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Medical College of Virginia Hospitals Richmond, VA
- Riverside Doctors' Hospital of Williamsburg Williamsburg, VA
Medical groups
- Mcv Associated Physicians (1,807 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 309
- Services billed
- 534
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 322 | 219 |
| Established patient office or other outpatient visit, 40-54 minutes | 78 | 61 |
| New patient office or other outpatient visit, 60-74 minutes | 24 | 24 |
| Established patient office or other outpatient visit, 20-29 minutes | 22 | 21 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 21 | 13 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 14 | 14 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Richmond, VA | 710 |
| Carbidopa-Levodopa Er (carbidopa/levodopa) Other prescribers in Richmond, VA | 339 |
| Clonazepam Other prescribers in Richmond, VA | 165 |
| Gabapentin Other prescribers in Richmond, VA | 150 |
| Amantadine (amantadine hcl) Other prescribers in Richmond, VA | 140 |
| Donepezil Hcl Other prescribers in Richmond, VA | 122 |
| Rytary (carbidopa/levodopa) Other prescribers in Richmond, VA | 113 |
| Primidone Other prescribers in Richmond, VA | 90 |
| Quetiapine Fumarate Other prescribers in Richmond, VA | 87 |
| Duloxetine Hcl Other prescribers in Richmond, VA | 72 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 9 payments worth $11,708 in total to this clinician.
| Amneal Pharmaceuticals LLC | $9,540 |
|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $2,000 |
| Medtronic, Inc. | $168 |
| Consulting Fee | $10,021 |
|---|---|
| Education | $1,519 |
| Food and Beverage | $168 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Amneal Pharmaceuticals LLC Feb 27, 2025 | Consulting Fee CREXONT · NEUROLOGY | $7,891 |
| Amneal Pharmaceuticals LLC Apr 29, 2025 | Education CREXONT · NEUROLOGY · in-kind | $1,350 |
| Takeda Pharmaceuticals U.S.A., Inc. Jan 9, 2025 | Consulting Fee | $1,000 |
| Takeda Pharmaceuticals U.S.A., Inc. Jun 11, 2025 | Consulting Fee | $1,000 |
| Amneal Pharmaceuticals LLC Mar 28, 2025 | Education in-kind | $169 |
| Amneal Pharmaceuticals LLC Feb 27, 2025 | Consulting Fee CREXONT · NEUROLOGY · in-kind | $130 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 6 industry-funded studies in 2025, from 3 companies. The companies reported $77,391 in research payments for these studies, mostly to the institutions running them.
- A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's Disease
UCB SA · Completed · NCT06055985 - Flexible-Dose Trial in Early Parkinson's Disease (PD)
AbbVie Inc. · Completed · NCT04223193 - ITI-214-202
Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.) - Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3)
AbbVie Inc. · Completed · NCT04542499 - Open-label Trial in Parkinson s Disease (PD) (TEMPO-4)
AbbVie Inc. - Open-label Trial in Parkinson's Disease (PD)
AbbVie Inc. · Completed · NCT04760769
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.